EU approves Bayer's Kovaltry for haemophilia A

FRANKFURT (Reuters) - The European Commission has approved Bayer's haemophilia A drug Kovaltry for the treatment of patients from all age groups, the company said on Monday.

http://ift.tt/xePdMM

from Reuters: Health News
via animenewspro